top of page
Nordic Life Science Platform - Fast-track China Entry
Medtech, Healthtech, Biotech, and Pharmaceuticals
Hainan Boao Lecheng International Medical Tourism Pilot Zone & Guangdong-Hong Kong-Macao Great Bay Area
About Us - Mission
About Us - Purpose & Mission
The Nordic Life Science Platform (NLSP), with offices in Copenhagen and Shanghai, is dedicated to effectively bridging the demand for innovative medical products and solutions in China with the supply of Nordic medtech, healthtech, biotech, and pharma companies.
We aim to promote collaboration and communication between both sides, driving innovation and development within health and life science.
NLSP gives mostly innovative Nordic life science companies a safer, easier, and faster access to the rapidly expanding Chinese healthcare market by taking advantage of the preferential policies in:
HBL and GBA serve as viable stepping-stones to the rest of the Chinese Healthcare Market in which our Step-by-Step Market Entry Model reduces the challenges and time-to-market by offering expert advise and supporting services.
NLSP also assists companies interested in investing in and partnering up with Nordic and Chinese life science companies by identifying and targeting potential investment opportunities that complement their product portfolios.
In late 2023, NLSP, Danish Life Science Cluster, and Lecheng Administration signed a joint Strategic Cooperation Agreement in Copenhagen within health & life science that was witnessed by Ms. XIE Jing, Vice Governor of Hainan Province.
China Office
Livat Office, 3F, Tower E, 788 Jinzhong Road
Changning District, 200235 Shanghai, China
中国上海市长宁区金钟路788号荟聚中心E栋3层邮编200235
Mobile: +86 136 1169 1358 and Email: info@nlsp.dk
Nordic Office
SOHO, Flæsketorvet 68,
1711 Copenhagen V., Denmark
Mobile: +45 2530 8027 and Email: info@nlsp.dk
bottom of page